Alkem Labs Gets EIR From US FDA For Baddi Facility
Drug firm Alkem Laboratories announced that the United States Food and Drug Administration (FDA) has issued an establishment inspection report (EIR) for its manufacturing facility at Baddi in Himachal Pradesh.US FDA inspected Baddi facility from February 17 to 21, 2020, Alkem Laboratories said in a BSE filing.The company said that the inspection has now been closed by the US FDA.Alkem Laboratories is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and neutraceutricals in India. Alkem has 21 manufacturing facilities: 19 in India and 2 in the US. The company had set up its research and development facility for ANDA development at Taloja in 2003.
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
